Clotrimazole troches

Phase 2Small molecule

HHadassah Medical Organization

Clotrimazole troches is one of 4 small molecule programs targeting Denture Stomatitis. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Denture StomatitisActive, not recruiting

Denture StomatitisPhase 2

Active, not recruiting

Competition

Competitive Landscape

6 competitors in Denture Stomatitis

#DrugCompanyPhaseTrials

Mycostatin

GGood Molecules, LLC

Phase 3

2 2

Curcumin

Merck & Co.

Phase 3

1 3

Rose Bengal

UUniversity of California, San Francisco

Phase 3

1 4

Clotrimazole troches

HHadassah Medical Organization

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Denture Stomatitis1 trial

Efficacy of Slow Release Clotrimazole Varnish Treating Denture Stomatitis Comparing to Traditional Treatment of Troches

Completed·HHadassah Medical Organization·Phase 2·NCT00835029·13 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Clotrimazole troches. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Clotrimazole troches compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Clotrimazole troches. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Hadassah Medical Organization company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: HHadassah Medical Organization

Clotrimazole troches

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Denture Stomatitis1 trial

References

Drug Info

Quick Facts

Related News